EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis

Rasha A Y Alnajmi, Dalal S Ali, Aliya A Khan

Endocrinology and Metabolism Clinics of North America · 2024-12 · 53 (4) · 607-618

DOI: 10.1016/j.ecl.2024.08.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2024-12. Verfasst von Rasha A Y Alnajmi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, McMaster University, 223 - 3075 Hospital Gate, Oakville, Ontario L6M 1M1, Canada. Hauptthemen laut MEDLINE: Femoral Fractures, Bisphosphonate-Associated Osteonecrosis of the Jaw, Osteoporosis, Bone Density Conservation Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-osteoporosis treatments reduce fracture risk but maybe associated with rare adverse events with long-term use such as atypical femoral fractures (AFFs) and medication-related osteonecrosis of the jaw (MRONJ). AFFs are rare but more likely with prolonged bisphosphonate use, whereas MRONJ incidence is higher in cancer patients on high-dose antiresorptive therapy. Following diagnosis, effective treatment options are available to manage both of these rare complications. An individualized treatment approach is advised with close monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Femoral FracturesBisphosphonate-Associated Osteonecrosis of the JawOsteoporosisBone Density Conservation AgentsHumansDiphosphonates

Stichwörter der Autor:innen

Atypical femoral fracturesBisphosphonateDenosumabOsteonecrosis of the jawOsteoporosis

Substanzen

Bone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, McMaster University, 223 - 3075 Hospital Gate, Oakville, Ontario L6M 1M1, Canada.
  • Division of Endocrinology and Metabolism, McMaster University, 223 - 3075 Hospital Gate, Oakville, Ontario L6M 1M1, Canada. Electronic address: draliyakhan@gmail.com.

Zitieren

APA

Alnajmi, R. A. Y., Ali, D. S., & Khan, A. A. (2024). Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Endocrinology and Metabolism Clinics of North America, 53(4), 607-618. https://doi.org/10.1016/j.ecl.2024.08.007

Vancouver

Alnajmi RAY, Ali DS, Khan AA. Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Endocrinology and Metabolism Clinics of North America. 2024;53(4):607-618. doi:10.1016/j.ecl.2024.08.007

BibTeX
@article{Alnajmi2024,
  author = {Alnajmi, Rasha A Y and Ali, Dalal S and Khan, Aliya A},
  title = {Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2024},
  volume = {53},
  number = {4},
  pages = {607--618},
  doi = {10.1016/j.ecl.2024.08.007}
}
Kostenlos starten →